在患有冠状病毒疾病感染的患者中,尼马特里尔维尔/里托纳维尔后多形红斑
José Wagner Leonel Tavares-Júnior1, José Carlos Jucá Pompeu Filho2, Luiz Eduardo Garcia Galvão3
1Universidade Federal do Ceará, Fortaleza, CE, Brasil.
多形红斑 (EM) 是一种皮肤疾病,可能发生在药物治疗后. 这项案例研究报告了一名患者在治疗COVID-19的涅马特雷尔维尔/里托纳维尔后发展出EM,在普雷尼松治疗后迅速改善.
科学领域:
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 多型红斑 (EM) 是一种免疫媒介的皮肤疾病,通常是由感染或药物引发的.
- 尼尔马特里尔维尔/里托纳维尔是一种抗病毒治疗COVID-19的药物.
- 尼尔马特里尔维尔/里托纳维尔与EM之间的关联尚未得到充分证实.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
18:46Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
相关概念视频
Myocarditis III: Medical Management
Retroviruses
Myocarditis II: Clinical Features and Diagnostic Tests
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
